Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 3,786 shares at $74.30 ($281K) on 2024-03-05, disclosed to the SEC on 2024-03-07.
Open-market sale of $281k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.30 | 1,893 | $141K | 50.0% |
| 2 | $74.30 | 1,893 | $141K | 50.0% |
| Total | $74.30 avg | 3,786 | $281K | 100% |
| Filing → |
| LGND | SELL | 2026-03-05 | $410K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |
| LGND | SELL | 2021-02-11 | $6.0M | — | Filing → |